Clinical practice guidelines for children with cancer presenting with fever to the emergency room

Pediatrics International

Volumn 53, Issue 6, 2011, Pages 902-905

  Pakakasama, Samart ^a   Surayuthpreecha, Kulvadee ^a   Pandee, Uthen ^a   Anurathapan, Usanarat ^a   Maleewan, Vimolratne ^a   Udomsubpayakul, Umaporn ^a   Butthep, Punnee ^a   Santanirand, Pitak ^a   Sirachainan, Nongnuch ^a   Hongeng, Suradej ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

childhood cancer; clinical practice guidelines; emergency room; febrile neutropenia

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; EMERGENCY CARE; FEBRILE NEUTROPENIA; FEVER; HOSPITAL ADMISSION; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; NEOPLASM; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPTIC SHOCK;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FEVER; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; INFANT; MALE; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SURVIVAL RATE; THAILAND; TREATMENT OUTCOME;

EID: 84255190923     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2011.03363.x     Document Type: Article

References (19)

1. Bailey LC, Relly AF, Rheingold SR,. Infections in pediatric patients with hematologic malignancies. Semin. Hematol. 2009; 46: 313-24.
2. Bate J, Ladhani S, Sharland M, et al,. Infection-related mortality in children with malignancy in England and Wales, 2003-2005. Pediatr. Blood Cancer 2009; 53: 371-4.
3. Santolaya ME, Alvarez AM, Becker A, et al,. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J. Clin. Oncol. 2001; 19: 3415-21. (Pubitemid 32642195)
4. Mendes AVA, Sapolnik R, Mendonca N,. New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients. J. Pediatr. (Rio. J.) 2007; 83: S54-63. (Pubitemid 46920392)
5. Link H, Bohme A, Cornely OA, et al,. Antimicrobial therapy of unexplained fever in neutropenic patients. Ann. Hematol. 2003; 82: S105-17.
6. Hartel C, Deuster M, Lehrnbecher T, Schultz C,. Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr. Blood Cancer 2007; 49: 767-73. (Pubitemid 47519510)
7. Hughes WT, Armstrong D, Bodey GP, et al,. 2002 guidelines for the use of antimicrobial agents in patients with cancer. Clin. Infect. Dis. 2002; 34: 730-51. (Pubitemid 34194843)
8. Perrone J, Hollander JE, Datner EM,. Emergency department evaluation of patients with fever and chemotherapy-induced neutropenia. J. Emerg. Med. 2004; 27: 115-19. (Pubitemid 38917192)
9. Salter C,. Clinical pathways in the emergency department: Successful implementation of "adult patients who are febrile following chemotherapy" pathway. Aust. Emerg. Nurs. J. 2005; 8: 27-34. (Pubitemid 44360591)
10. Corey AL, Snyder S,. Antibiotics in 30 minutes or less for febrile neutropenic patients: A quality control measure in a new hospital. J. Pediatr. Oncol. Nurs. 2008; 25: 208-12.
11. Frazier A, Pruette CS,. Cardiology. In:, Custer JW, Rau RE, (eds). The Harriet Lane Handbook, 18th edn. Elsevier, Philadelphia, 2009; 173-221.
12. American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care of paediatric and neonatal patients, Part 11: Pediatric basic life support. Circulation 2005; 112: IV 156-66.
13. American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care of paediatric and neonatal patients, Part 12: Pediatric advanced life support. Circulation 2005; 112: IV 167-87.
14. Tamura K,. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: Validation by the Japan Febrile Neutropenia Study Group. Int. J. Antimicrob. Agents 2005; 26 (Suppl.): S123-7. (Pubitemid 41606722)
15. Zuckermann J, Moreira LB, Stoll P, Moreira LM, Kuchenbecker RS, Polanczyk CA,. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Ann. Hematol. 2008; 87: 139-45.
16. Nirenberg A, Mulhearn L, Lin S, Larson E,. Emergency department waiting times for patients with cancer with febrile neutropenia: A pilot study. Oncol. Nurs. Forum 2004; 13: 711-15.
17. Basu SK, Fernandez ID, Fisher SG, Asselin BL, Lyman GH,. Length of stay and mortality associated with febrile neutropenia among children with cancer. J. Clin. Oncol. 2005; 23: 7958-66. (Pubitemid 46657396)
18. Seeom K,. A causal model for the effectiveness of internal quality assurance for the health science area. J. Med. Assoc. Thai. 2005; 88: 1419-25.
19. Leone AF, Standoli F, Hirth V,. Implementing a pain management program in a long-term care facility using a quality improvement approach. J. Am. Med. Dir. Assoc. 2009; 10: 67-73.